These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7988036)

  • 1. Serum type IV collagen and prolyl hydroxylase levels: effect of gender and age.
    Tamaro G; Moretti M; Marchi P; Mangiarotti M; Pozzato G
    Clin Chim Acta; 1994 Aug; 228(2):205-10. PubMed ID: 7988036
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of interferon therapy on fibrosis serum markers in HCV-positive chronic liver disease.
    Mazzoran L; Tamaro G; Mangiarotti MA; Marchi P; Baracetti S; Gerini U; Fanni-Cannelles M; Zorat F; Pozzato G
    Eur J Gastroenterol Hepatol; 1998 Feb; 10(2):125-31. PubMed ID: 9581987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum markers for connective tissue turnover in patients with chronic hepatitis B and chronic hepatitis C: a comparative analysis.
    Murawaki Y; Ikuta Y; Nishimura Y; Koda M; Kawasaki H
    J Hepatol; 1995 Aug; 23(2):145-52. PubMed ID: 7499785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate therapy and liver fibrosis: are human prolyl hydroxylase and type IV collagen reliable and sensitive markers?
    Tamaro G; Danek GM; Mangiarotti MA; Tamaro P; Zanazzo GA
    Int J Clin Lab Res; 1995; 25(1):55. PubMed ID: 7787212
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatic fibrosis and its serum markers].
    Okabe K
    Rinsho Byori; 1992 Dec; 40(12):1258-64. PubMed ID: 1339165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are serum type III procollagen and prolyl hydroxylase useful as noninvasive markers of liver disease in patients with cystic fibrosis?
    Leonardi S; Giambusso F; Sciuto C; Castiglione S; Castiglione N; La Rosa M
    J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):603-5. PubMed ID: 9822332
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of serum prolyl hydroxylase in diabetic microangiopathy].
    Shioi A; Nishizawa Y; Morii H
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():126-8. PubMed ID: 9513402
    [No Abstract]   [Full Text] [Related]  

  • 8. Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. I. Prolyl hydroxylase.
    Kuutti-Savolainen ER; Risteli J; Miettinen TA; Kivirikko KI
    Eur J Clin Invest; 1979 Feb; 9(1):89-95. PubMed ID: 222594
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic prolyl hydroxylase and collagen synthesis in patients with alcoholic liver disease.
    Mann SW; Fuller GC; Rodil JV; Vidins EI
    Gut; 1979 Oct; 20(10):825-32. PubMed ID: 230128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of the determination of serum immunoreactive prolyl hydroxylase (SIRPH) in hepatic fibrosis].
    Suzuki H; Suzuki M; Okabe K; Uchikoshi T
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1265-71. PubMed ID: 2822984
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased deposition and serum level of type IV collagen in patients with extrahepatic biliary atresia.
    Shirahase I; Ooshima A; Tanaka K; Ozawa K; Yamabe H; Yamamoto T
    J Pediatr Surg; 1993 Jun; 28(6):847-50. PubMed ID: 8392544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive prolyl hydroxylase in human skin, serum and synovial fluid: changes in the content and components with age.
    Tuderman L; Kivirikko KI
    Eur J Clin Invest; 1977 Aug; 7(4):295-9. PubMed ID: 196862
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum immunoreactive prolyl hydroxylase in liver disease.
    Tuderman L; Risteli J; Miettinen TA; Kivirikko KI
    Eur J Clin Invest; 1977 Dec; 7(6):537-41. PubMed ID: 204493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum enzymes of collagen synthesis and type III procollagen amino-propeptide in Nigerian patients with sickle cell disease.
    Bolarin M
    J Clin Chem Clin Biochem; 1986 Jul; 24(7):433-6. PubMed ID: 3016143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of four serum markers of fibrosis in the diagnosis of cirrhosis.
    Fabris C; Falleti E; Federico E; Toniutto P; Pirisi M
    Ann Clin Biochem; 1997 Mar; 34 ( Pt 2)():151-5. PubMed ID: 9133247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is serum prolyl 4-hydroxylase useful as noninvasive marker of liver fibrosis in patients with biliary atresia?
    Kobayashi H; Tamura T; Yamataka A; Lane GJ; Miyano T
    J Pediatr Surg; 2005 Aug; 40(8):1366-7. PubMed ID: 16080952
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical significance of serum prolyl hydroxylase analysis in the diagnosis of diabetic diseases].
    Shioi A; Nishizawa Y; Morii H
    Nihon Rinsho; 1990 Dec; 48 Suppl():370-3. PubMed ID: 1964975
    [No Abstract]   [Full Text] [Related]  

  • 18. Human prolyl-hydroxylase: only a marker of hepatic damage?
    Tamaro G; Pozzato G; Moretti M
    Int J Clin Lab Res; 1993; 23(4):228. PubMed ID: 8123880
    [No Abstract]   [Full Text] [Related]  

  • 19. Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis.
    Hørslev-Petersen K; Bentsen KD; Halberg P; Junker P; Kivirikko KI; Majamaa K; Risteli L; Risteli J; Lorenzen I
    Clin Exp Rheumatol; 1988; 6(2):129-34. PubMed ID: 2846219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in levels of serum and urinary collagen-related substances in growth hormone deficient children following discontinuation of growth hormone therapy.
    Kuno T; Miyazaki S
    Endocr J; 1998 Apr; 45 Suppl():S151-3. PubMed ID: 9790252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.